Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,427 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)

NCT03289182

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
View all 25 locations
View Trial Details
Completed

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

NCT01180322

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Universitätsklinikum Innsbruck Innsbruck, Austria
  • Krankenhaus der Barmherzigen Schwestern Linz, Austria
  • Elisabethinen Krankenhaus Linz Linz, Austria
  • Landeskliniken Salzburg Salzburg, Austria
View all 44 locations
View Trial Details
Completed

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

NCT01077544

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Novartis Investigative Site Bordeaux, Aquitaine, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Poitiers, France
View Trial Details
Completed

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

NCT01242774

Conditions
Acute Myeloid Leukemia (AML), Chromosome Aberrations, Hematologic Diseases, +8 more
Locations
  • Stanford University Medical Center Stanford U Stanford, California, United States
  • Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States
  • Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital Columbus, Ohio, United States
  • Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) Charleston, South Carolina, United States
View Trial Details
Completed

A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia

NCT01055483

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Dresden, Germany
  • Novartis Investigative Site Frankfurt, Germany
View Trial Details

Related conditions